BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12566299)

  • 21. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ; Liu ZJ; Shimoi K; Zhu BT
    Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosensitization effect of zidovudine on human malignant glioma cells.
    Zhou FX; Liao ZK; Dai J; Xiong J; Xie CH; Luo ZG; Liu SQ; Zhou YF
    Biochem Biophys Res Commun; 2007 Mar; 354(2):351-6. PubMed ID: 17223082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
    Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
    Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
    Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
    Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
    Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of telomerase limits the growth of human cancer cells.
    Hahn WC; Stewart SA; Brooks MW; York SG; Eaton E; Kurachi A; Beijersbergen RL; Knoll JH; Meyerson M; Weinberg RA
    Nat Med; 1999 Oct; 5(10):1164-70. PubMed ID: 10502820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
    Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS
    Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
    Zheng X; Chang RL; Cui XX; Avila GE; Hebbar V; Garzotto M; Shih WJ; Lin Y; Lu SE; Rabson AB; Kong AN; Conney AH
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3444-51. PubMed ID: 16740769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells.
    Huang JJ; Lin MC; Bai YX; Jing DD; Wong BC; Han SW; Lin J; Xu B; Huang CF; Kung HF
    Cancer Res; 2002 Jun; 62(11):3226-32. PubMed ID: 12036938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of antisense human telomerase RNA toward cancer therapy].
    Naka K; Yokozaki H; Tahara H; Tahara E
    Nihon Rinsho; 1998 May; 56(5):1131-5. PubMed ID: 9613109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
    Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
    Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergy between 3'-azido-3'-deoxythymidine and paclitaxel in human pharynx FaDu cells.
    Johnston JS; Johnson A; Gan Y; Wientjes MG; Au JL
    Pharm Res; 2003 Jul; 20(7):957-61. PubMed ID: 12880279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
    Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
    Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenoviral-mediated retinoblastoma 94 produces rapid telomere erosion, chromosomal crisis, and caspase-dependent apoptosis in bladder cancer and immortalized human urothelial cells but not in normal urothelial cells.
    Zhang X; Multani AS; Zhou JH; Shay JW; McConkey D; Dong L; Kim CS; Rosser CJ; Pathak S; Benedict WF
    Cancer Res; 2003 Feb; 63(4):760-5. PubMed ID: 12591722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
    Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA.
    Li S; Rosenberg JE; Donjacour AA; Botchkina IL; Hom YK; Cunha GR; Blackburn EH
    Cancer Res; 2004 Jul; 64(14):4833-40. PubMed ID: 15256453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule.
    Jang SH; Wientjes MG; Au JL
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1035-42. PubMed ID: 11181938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.